RNA
NASDAQ · Biotechnology
Avidity Biosciences Inc
$9.19
+0.24 (+2.68%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-78.29%
YTD
-87.25%
Open$8.97
Previous Close$8.95
Day High$9.34
Day Low$8.94
52W High$73.06
52W Low$9.44
Volume—
Avg Volume487.1K
Market Cap162.85M
P/E Ratio—
EPS$-5.04
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$72.38
Below
SMA 200
$51.57
Below
RSI (14)
65.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.79M | 12.49M | 2.36B |
| Net Income | -52,627,369 | -29,894,365 | -651,372,475 |
| Profit Margin | -265.9% | -252.6% | -27.6% |
| EBITDA | -52,421,765 | -31,431,883 | -865,943,607 |
| Free Cash Flow | — | — | -400,975,764 |
| Rev Growth | +58.4% | +58.4% | +6.9% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |